Amid global uncertainty, market expert Narendra Solanki advises theme-based investing. He highlights opportunities in ...

The pharmaceutical manufacturer filed a Worker Adjustment and Retraining Notification with the Pennsylvania Department of ...

Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of an antifungal medication in the US ...

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this movie before. A company leans hard on ...

The headquarters for Boehringer Ingelheim in Ridgfield. Photo courtesy of Boehringer Ingelheim RIDGEFIELD – The biopharmaceutical company Boehringer Ingelheim will ...

A push to reshore some drug production and progress in advanced manufacturing technologies have been prominent trends this year, industry leaders say.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Amneal Pharmaceuticals and mAbxience received Food and Drug Administration approval for two biosimilars. The companies said Monday that the FDA greenlit Biologics Licensing Applications for Boncresa, ...

New Jersey-based pharma companies joined White House drug pricing deals aimed at lowering prescription drug costs under Trump’s policy.

Samsung Biologics acquires Human Genome Sciences from GSK for $280 million, expanding its US manufacturing footprint. The ...

The South Korean drug manufacturer reached an agreement to buy the two-building campus from GSK, which is also exiting an R&D facility in Rockville.

The Maryland life sciences campus is part of a package deal alongside Human Genome Sciences, which Samsung is acquiring from ...